Latest News

med fusion introduces EGFR liquid biopsy service with Roche’s mutation test

US-based laboratory diagnostics provider med fusion has introduced a new plasma-based epidermal growth factor receptor (EGFR) liquid biopsy service, which is integrated with Swiss healthcare...

med fusion introduces EGFR liquid biopsy service with Roche’s mutation test

FDA issues warning on accuracy of Magellan Diagnostics’ lead tests

FDA issues warning on accuracy of Magellan Diagnostics’ lead tests

Mel-Mont Medical develops self-collected diagnostic test for cervical cancer

Mel-Mont Medical has developed a new preventive comprehensive diagnostic system for cervical cancer called Mía by...

Mel-Mont Medical develops self-collected diagnostic test for cervical cancer

UK and China develop new low-cost graphene sensor for hepatitis diagnosis

UK and China have collaborated on a new project to develop an easy, low-cost sensor for simultaneous diagnosis of hepatitis A, B and...

UK and China develop new low-cost graphene sensor for hepatitis diagnosis

Novel Diagnostics Lend Credence to Empiric Therapy for Suspected UTIs

Novel Diagnostics Lend Credence to Empiric Therapy for Suspected UTIs

GenomeDx and Color to offer Color Test for genetic testing in prostate cancer

GenomeDx Biosciences has partnered with Color to offer Color Test for the genetic testing of patients diagnosed with prostate...

GenomeDx and Color to offer Color Test for genetic testing in prostate cancer

Beaumont Health develops new urine test to detect Zika virus

Beaumont Health develops new urine test to detect Zika virus

Photocure reports positive results from the Phase III trial of BLFC with Cysview/Hexvix

Norway-based speciality pharmaceutical firm Photocure has reported positive results from a Phase III trial of Blue Light Flexible Cystoscopy (BLFC) with Cysview/Hexvix to detect patients at risk...

Photocure reports positive results from the Phase III trial of BLFC with Cysview/Hexvix

UK's ICR develops new test to predict targeted prostate cancer treatment outcome

UK's ICR develops new test to predict targeted prostate cancer treatment outcome

FDA grants approval to Roche's complementary test for urothelial carcinoma

FDA grants approval to Roche's complementary test for urothelial carcinoma

MDxHealth and Exact Sciences collaborate for epigenetics and molecular diagnostics

MDxHealth has entered a new five-year agreement with diagnostics company Exact Sciences to share technologies that will be discovered and developed in the epigenetics and molecular diagnostic...

MDxHealth and Exact Sciences collaborate for epigenetics and molecular diagnostics

bioLytical introduces HIV self-test in Belgium

Canada-based bioLytical Laboratories has introduced INSTI HIV Self Test in pharmacies across...

bioLytical introduces HIV self-test in Belgium

Meridian develops new sensitive diagnostic test for malaria

US-based life science company Meridian Bioscience has developed a new molecular-based, field laboratory-deployed test 'illumigene Malaria' to diagnose...

Meridian develops new sensitive diagnostic test for malaria

STAT-Dx unveils new molecular diagnostics platform

Spanish diagnostic solutions provider STAT-Dx is set to unveil its new in-vitro diagnostics system DiagCORE at the 27th European Congress of Clinical Microbiology and Infectious Diseases...

STAT-Dx unveils new molecular diagnostics platform

Grail studies STRIVE blood tests to detect cancer early

Grail studies STRIVE blood tests to detect cancer early

Roche collaborates with Sentara Consolidated Laboratories for diagnostic solutions

Pharmaceutical and diagnostic firm Roche has entered a strategic alliance with Sentara Consolidated Laboratories, recognising the organisation as a Roche Molecular Centre of Excellence...

Roche collaborates with Sentara Consolidated Laboratories for diagnostic solutions

BMS and Nordic Bioscience partner to develop biomarker technology for fibrotic diseases

US-based biopharmaceutical company Bristol-Myers Squibb (BMS) has entered a collaboration agreement with Danish biotech firm Nordic Bioscience to develop biomarker technology to detect...

BMS and Nordic Bioscience partner to develop biomarker technology for fibrotic diseases

FDA grants clearance to Philips' new digital pathology solution

FDA grants clearance to Philips' new digital pathology solution

HTG and Daiichi Sankyo partner to develop diagnostic tests

US-based diagnostic firm HTG Molecular Diagnostics and Japanese pharmaceutical company Daiichi Sankyo have entered a master service agreement to develop diagnostic tests at the former's...

HTG and Daiichi Sankyo partner to develop diagnostic tests

Roche launches new prostate cancer diagnostic test

Roche launches new prostate cancer diagnostic test

Strand Life Sciences introduces new liquid biopsy tests for cancer

India-based bioinformatics firm Strand Life Sciences has introduced a new line of liquid biopsy tests STRAND LB to detect traces of cancer from a blood...

Strand Life Sciences introduces new liquid biopsy tests for cancer